Guled Mohamed, Pazzaglia Laura, Borze Ioana, Mosakhani Neda, Novello Chiara, Benassi Maria Serena, Knuutila Sakari
Department of Pathology, Haartman Institute and HUSLAB, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Genes Chromosomes Cancer. 2014 Aug;53(8):693-702. doi: 10.1002/gcc.22179. Epub 2014 Apr 26.
The rare and highly aggressive adult soft tissue sarcomas leiomyosarcoma (LMS) and undifferentiated pleomorphic sarcoma (UPS) contain complex genomes characterized by a multitude of rearrangements, amplifications, and deletions. Differential diagnosis remains a challenge. MicroRNA (miRNA) profiling was conducted on a series of LMS and UPS samples to initially investigate the differential expression and to identify specific signatures useful for improving the differential diagnosis. Initially, 10 high-grade LMS and 10 high-grade UPS were profiled with a miRNA microarray. Two cultured human mesenchymal stem cell samples were used as controls. 38 and 46 miRNAs classified UPS and LMS samples, respectively, into separate groups compared to control samples. When comparing the two profiles, miR-199b-5p, miR-320a, miR-199a-3p, miR-126, miR-22 were differentially expressed. These were validated by RT-PCR on a further series of 27 UPS and 21 LMS for a total of 68 cases. The levels of miR-199-5p and miR-320a, in particular, confirmed the microarray data, the former highly expressed in UPS and the latter in LMS. Immunohistochemistry was performed on all 68 cases to confirm original diagnosis. Recently reported LMS- and UPS-associated genes were correlated with miRNA targets based on target algorithms of three databases. Several genes including IMP3, ROR2, MDM2, CDK4, and UPA, are targets of differentially expressed miRNAs. We identified miRNA expression patterns in LMS and UPS, linking them to chromosomal regions and mRNA targets known to be involved in tumor development/progression of LMS and UPS.
罕见且侵袭性强的成人软组织肉瘤——平滑肌肉瘤(LMS)和未分化多形性肉瘤(UPS),其基因组复杂,具有大量重排、扩增和缺失特征。鉴别诊断仍然是一项挑战。对一系列LMS和UPS样本进行了微小RNA(miRNA)分析,以初步研究差异表达,并识别有助于改善鉴别诊断的特定特征。最初,使用miRNA微阵列对10例高级别LMS和10例高级别UPS进行分析。将两个培养的人间充质干细胞样本用作对照。与对照样本相比,分别有38个和46个miRNA将UPS和LMS样本分为不同组。比较这两个分析图谱时,miR-199b-5p、miR-320a、miR-199a-3p、miR-126、miR-22存在差异表达。通过逆转录聚合酶链反应(RT-PCR)在另外一系列共68例样本(27例UPS和21例LMS)上对这些结果进行了验证。特别是miR-199-5p和miR-320a的水平证实了微阵列数据,前者在UPS中高表达,后者在LMS中高表达。对所有68例病例进行免疫组织化学检查以确认最初诊断。基于三个数据库的靶标算法,将最近报道的与LMS和UPS相关的基因与miRNA靶标进行关联。包括IMP3、ROR2、MDM2、CDK4和UPA在内的几个基因是差异表达miRNA的靶标。我们在LMS和UPS中鉴定出miRNA表达模式,将它们与已知参与LMS和UPS肿瘤发生/进展的染色体区域和mRNA靶标联系起来。